HHS Secretary Says Pfizer Vaccine Could Be Ready For Public Distribution By Spring
Just a day after Pfizer announced that its COVID-19 vaccine candidate was more than 90 percent effective in clinical trials.
Just a day after Pfizer announced that its COVID-19 vaccine candidate was more than 90 percent effective in clinical trials.
Yesterday Pfizer shared promising news about the efficacy of their vaccine in recent trials, suggesting their vaccine was more than 90% effective.
The number of coronavirus (COVID-19) cases reported around the world went over the 40 million mark over the weekend, according to the semi-official tally maintained by Johns Hopkins University.
More than 60,000 new cases of COVID-19 were reported in the United States on Tuesday, marking a grim new record for cases reported in a 24-hour period.
Coronavirus (COVID-19) tally as compiled by Johns Hopkins University. (Previous numbers in parentheses.)
With the coronavirus — COVID-19 — spreading around the world with increasing speed, U.S. health officials are stepping up efforts to contain it.
Mayor Bill de Blasio, Governor Andrew Cuomo, Senate Majority Leader Andrea Stewart-Cousins, Assembly Speaker Carl Heastie, and New York labor leaders today sent a letter to the New York Congressional Delegation.
Today, the New York State Senate voted to pass S.8182-A (Hoylman)/A.10508-A (Paulin), legislation that would make a COVID-19 vaccine widely available after it receives FDA approval.